Mitochondrial damage and histotoxic hypoxia: A pathway of tissue injury in inflammatory brain disease?

Acta Neuropathologica

Volumn 109, Issue 1, 2005, Pages 49-55

  Aboul Enein, F ^a   Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Histotoxic hypoxia; Inflammatory brain disease; Mitochondrial dysfunction; Multiple sclerosis

Indexed keywords

AUTACOID; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; MITOCHONDRIAL DNA; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN; N ACETYLASPARTIC ACID; PROTEOLIPID PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DIFFUSE AXONAL INJURY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENCEPHALITIS; HUMAN; IMMUNOCYTOCHEMISTRY; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; WHITE MATTER;

ANOXIA; BRAIN DISEASES; CEREBROVASCULAR TRAUMA; HUMANS; INFLAMMATION; MITOCHONDRIAL DISEASES; MULTIPLE SCLEROSIS; NITROGEN; REACTIVE OXYGEN SPECIES;

EID: 14244254361     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-004-0954-8     Document Type: Review

References (60)

1. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 62:25-33
2. Archelos JJ, Hartung HP (2000) Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 23:317-327 10.1016/ S0166-2236(00)01575-7
3. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458-468 10.1002/ana.20016
4. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S (2000) The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci USA 97:14602-14607
5. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48:285-296 1:CAS:528:DC%2BD3cXms1OhsLY%3D
6. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR (2002) Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 277:39728-39738 10.1074/jbc.M204619200
7. Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, Heales SJ (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 68:2227-2240 1:CAS:528:DyaK2sXjsVOgu7g%3D
8. Brorson JR, Schumacker PT, Zhang H (1999) Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology. J Neurosci 19:147-158
9. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C (1989) Differential ultrastructural localization of myelin basic protein/myelin oligodendroglial glycoprotein and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 52:296-304 1:CAS:528:DyaK2sXjsVOgu7g%3D
10. Christians ES, Yan LJ, Benjamin IJ (2002) Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury. Crit Care Med 30:S43-S50 10.1097/00003246-200201001-00006
11. Courville CB (1970) Concentric sclerosis. In: Vinken PJ Bruyn GW (eds) Multiple sclerosis and other demyelinating diseases. North-Holland, Amsterdam, pp 437-451
12. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56:10-20 8990125
13. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C (2001) N-Acetylaspartate a marker of both cellular dysfunction and neuronal loss: Its relevance to studies of acute brain injury. J Neurochem 77:408-415 10.1046/j.1471-4159.2001.00285.x
14. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL (1999) In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 122:1933-1939 10.1093/brain/122.10.1933
15. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124:1813-1820 10.1093/brain/124.9.1813
16. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399 10.1093/brain/ 120.3.393
17. Ferraro A (1933) Experimental toxic encephalopathy. Diffuse sclerosis following subcutaneous injection of potassium-cyanide. Psychiatr Q 7:267-283
18. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13:554-573 1:CAS:528:DC%2BD3sXpslCgurc%3D
19. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB (1999) Nitric oxide mitochondria and neurological disease. Biochim Biophys Acta 1410:215-228 1:STN:280:DyaK1M7nslCksg%3D%3D
20. Itoyama Y, Sternberger NH, Webster HD, Quarles RH, Cohen SR, Richardson EP Jr (1980) Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann Neurol 7:167-177 1:CAS:528:DyaL3cXhslyls78%3D
21. Itoyama Y, Webster HD, Sternberger NH, Richardson EP Jr, Walker DL, Quarles RH, Padgett BL (1982) Distribution of papovavirus myelin-associated glycoprotein and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol 11:396-407 1:STN:280:Bi2B2MrhvFA%3D
22. Kalman B, Leist TP (2003) A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromolecular Med 3:147-158 10.1385/NMM:3:3:147
23. Kawakami N, Lassmann S, Li Z, Odoardi F, Ritter T, Ziemssen T, Klinkert WEF, Ellwart JW, Bradl M, Krivacic K, Lassmann H, Ransohoff RM, Volk HD, Wekerle H, Linington C, Flugel A (2004) The activation status of neuroantigen-specific t cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 199:185-197 10.1084/jem.20031064
24. Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE (1994) Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 36:109-112 1:CAS:528:DyaK2cXmtVagsb0%3D
25. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95:189-197 1:CAS:528:DC%2BD3cXhslKhtg%3D%3D
26. Kornek B, Lassmann H (1999) Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 9:651-656 1:STN:280:DyaK1MvksFSqsA%3D%3D
27. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active inactive and remyelinated lesions. Am J Pathol 157:267-276 1:STN:280:DC%2BD3czptVagsw%3D%3D
28. Leist M, Jaattela M (2001) Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598 10.1038/35085008
29. Leist TP, Gobbini MI, Frank JA, McFarland HF (2001) Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch Neurol 58:57-60 10.1001/ archneur.58.1.57
30. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443-454 1:STN:280:BieC287ivVI%3D
31. Liu JSH, Zhao ML, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057-2066 1:CAS:528:DC%2BD3MXkvFyksb0%3D
32. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C, Kalman B (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95-103 10.1016/S0022-510X(00)00343-9
33. Lu ZH, Chakraborty G, Ledeen RW, Yahya D, Wu G (2004) N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Res Mol Brain Res 122:71-78 10.1016/j.molbrainres.2003.12.002
34. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707-717 10.1002/ 1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
35. McDonough J Dutta R Gudz T et al (2003) Decreases in GABA and mitochondrial genes are implicated in MS cortical pathology through microarray analysis of postmortem MS cortex. Soc Neurosci Abstr 213.212
36. Narayanan S, Stefano N de, Francis GS, Arnaoutelis R, Caramanos Z, Collins DL, Pelletier D, Arnason BGW, Antel JP, Arnold DL (2001) Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol 248:979-986 10.1007/s004150170052
37. Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25:313-319 10.1016/S0166-2236(02)02154-9
38. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952 10.1056/NEJM200009283431307
39. Owens T (2003) The enigma of multiple sclerosis: Inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 16:259-265 10.1097/00019052-200306000-00003
40. Petty MA, Wettstein JG (1999) White matter ischaemia. Brain Res Brain Res Rev 31:58-64 10.1016/S0165-0173(99)00025-9
41. Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible. Brain 120:2149-2157 10.1093/brain/120.12.2149
42. Schipper HM (2004) Heme oxygenase-1: Transducer of pathological brain iron sequestration under oxidative stress. Ann N Y Acad Sci 1012:84-93
43. Semenza GL (2000) Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106:809-812 1:CAS:528:DC%2BD3cXntVyiurc%3D
44. Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437-448 10.1038/nrn1408
45. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R (2001) N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 18:977-991 10.1089/08977150152693683
46. Smith KJ, Lassmann H (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-241 10.1016/S1474-4422(02)00102-3
47. Smith KJ, Kapoor R, Felts PA (1999) Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 9:69-92 1:CAS:528:DyaK1MXht1CmsLc%3D
48. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470-476 1:CAS:528:DC%2BD3MXjtVyjtL0%3D
49. Smith T, Groom A, Zhu B, Turski L (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6:62-66 10.1038/71548
50. Stys PK (1998) Anoxic and ischemic injury of myelinated axons in CNS white matter: From mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 18:2-25
51. 2+ exchanger. J Neurosci 12:430-439 1:CAS:528:DyaK38XhslWnurc%3D
52. Tanaka K, Nogawa S, Suzuki S, Dembo T, Kosakai A (2003) Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. Brain Res 989:172-179 10.1016/S0006-8993(03)03317-1
53. Trapp BD, Quarles RH (1984) Immunocytochemical localization of the myelin-associated glycoprotein. Fact or artifact? J Neuroimmunol 6:231-249 10.1016/0165-5728(84)90011-0
54. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285 10.1056/NEJM199801293380502
55. Vass K, Welch WJ, Nowak TS Jr (1988) Localization of 70-kDa stress protein induction in gerbil brain after ischemia. Acta Neuropathol 77:128-135 1:STN:280:BiaC2cjltVw%3D
56. Wakefield AJ, More LJ, Difford J, McLaughlin JE (1994) Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47:129-133
57. Waxman SG (2001) Acquired channelopathies in nerve injury and MS. Neurology 56:1621-1627 1:CAS:528:DC%2BD3MXltFeisbk%3D
58. Waxman SG, Black JA, Stys PK, Ransom BR (1992) Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res 574:105-119 10.1016/0006-8993(92)90806-K
59. Wisniewski HM, Bloom BR (1975) Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J Exp Med 141:346-359 10.1084/jem.141.2.346
60. Yam PS, Dewar D, McCulloch J (1998) Axonal injury caused by focal cerebral ischemia in the rat. J Neurotrauma 15:441-450 1:STN:280:DyaK1c3oslOhtw%3D%3D